Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ELV
stocks logo

ELV

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
49.63B
+10.32%
3.194
-16.83%
50.83B
+4.24%
10.857
-9.3%
51.27B
+3.74%
8.133
-7.99%
Estimates Revision
The market is revising Upward the revenue expectations for Elevance Health, Inc. (ELV) for FY2025, with the revenue forecasts being adjusted by 0.49% over the past three months. During the same period, the stock price has changed by 15.18%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.49%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.33%
In Past 3 Month
Stock Price
Go Up
up Image
+15.18%
In Past 3 Month
Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is 392.07 USD with a low forecast of 343.00 USD and a high forecast of 425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is 392.07 USD with a low forecast of 343.00 USD and a high forecast of 425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
3 Hold
0 Sell
Strong Buy
Current: 359.070
sliders
Low
343.00
Averages
392.07
High
425.00
Current: 359.070
sliders
Low
343.00
Averages
392.07
High
425.00
TD Cowen
Buy
upgrade
$380 -> $400
2025-11-26
Reason
TD Cowen
Price Target
$380 -> $400
2025-11-26
upgrade
Buy
Reason
TD Cowen raised the firm's price target on Elevance Health to $400 from $380 and keeps a Buy rating on the shares. The firm said it is a Best Idea for 2026. Managed care continues to be a complicated investment landscape, but we see the company's current 2026 EPS consensus as appropriate and a basis for growth.
Mizuho
Outperform
to
NULL
downgrade
$420 -> $400
2025-11-03
Reason
Mizuho
Price Target
$420 -> $400
2025-11-03
downgrade
Outperform
to
NULL
Reason
Mizuho lowered the firm's price target on Elevance Health to $400 from $420 and keeps an Outperform rating on the shares. The firm reduced 2026 and 2027 earnings estimates to reflect additional headwinds in Carelon related to the expected regulatory driven membership changes. The firm assumes Elevance faces membership pressure in its Medicaid, Medicare Advantage and the health insurance exchange businesses due to the potential expiration of the enhanced advanced premium tax credits.
JPMorgan
NULL -> Overweight
upgrade
$384 -> $394
2025-10-28
Reason
JPMorgan
Price Target
$384 -> $394
2025-10-28
upgrade
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Elevance Health to $394 from $384 and keeps an Overweight rating on the shares. The firm updated the company's model post the earnings report.
TD Cowen
Buy
maintain
$330 -> $380
2025-10-23
Reason
TD Cowen
Price Target
$330 -> $380
2025-10-23
maintain
Buy
Reason
TD Cowen raised the firm's price target on Elevance Health to $380 from $330 and keeps a Buy rating on the shares. The firm noted the company maintained FY25 guide but FY26 implied lower versus consensus on a more negative MDCD outlook, offset by more upbeat MA expectations.
Barclays
Overweight
downgrade
$395 -> $385
2025-10-22
Reason
Barclays
Price Target
$395 -> $385
2025-10-22
downgrade
Overweight
Reason
Barclays lowered the firm's price target on Elevance Health to $385 from $395 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q3 report.
Goldman Sachs
Neutral
initiated
$343
2025-10-14
Reason
Goldman Sachs
Price Target
$343
2025-10-14
initiated
Neutral
Reason
Goldman Sachs initiated coverage of Elevance Health with a Neutral rating and $343 price target. The managed care industry faces its most significant underwriting downturn in over 15 years, the analyst tells investors in a research note. Goldman recommends increased exposure to Medicare Advantage as it sees a margin recovery phase beginning in 2026. However, the firm does not see the Medicare Advantage recovery playing out uniformly across the group in 2026. The analyst also sees a longer path to cyclical recovery in Medicaid and the healthcare exchange.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Elevance Health Inc (ELV.N) is 13.37, compared to its 5-year average forward P/E of 13.75. For a more detailed relative valuation and DCF analysis to assess Elevance Health Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
13.75
Current PE
13.37
Overvalued PE
15.56
Undervalued PE
11.94

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
10.26
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
11.35
Undervalued EV/EBITDA
9.17

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.62
Current PS
0.00
Overvalued PS
0.74
Undervalued PS
0.50
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 135.25% over the last quarter.
Sold
Bought
Congress Trading
Congress areSelling! The selling amount has increased306.25%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ELV News & Events

Events Timeline

(ET)
2025-12-08
18:40:00
Cantor Fitzgerald Predicts 2026 Will Be Challenging for Medicaid
select
2025-12-08
06:40:00
Republicans Yet to Agree on Healthcare Strategy Ahead of Vote
select
link
2025-11-25 (ET)
2025-11-25
06:20:32
Speaker Johnson cautions that House Republicans oppose ACA subsidies, according to WSJ.
select
link
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.5
03:30 AMBusinesswire
Elevance Health Expands Health Plans to Support Broader Member Needs
  • Evolution of Health Plans: Elevance Health is evolving its health plans in partnership with care providers to support broader member needs, including cancer diagnoses, mental health crises, and unexpected health issues during pregnancy, aiming to enhance the overall health experience for members.
  • Personalized Care: By providing funds for nutritious food, over-the-counter medications, and transportation services, Elevance Health's Medicare Advantage and Medicaid plans help members meet their individual health and social needs, thereby improving health outcomes.
  • Simplifying Healthcare Experience: Through the Sydney app, Elevance Health delivers easily understandable resources that assist members in better understanding and utilizing their benefits, enhancing accessibility and efficiency in healthcare services.
  • Community Collaboration: Elevance Health invests in community relationships, leveraging data to understand health-impacting factors, supporting schools and local markets, and promoting overall community health improvements.
[object Object]
Preview
7.5
03:13 AMNewsfilter
Elevance Health Enhances Healthcare Services, Reaching Over 109 Million Consumers
  • Comprehensive Health Support: Elevance Health enhances support for members facing cancer diagnoses, mental health crises, and unexpected pregnancy health issues through partnerships with care providers, significantly improving health outcomes and member confidence in navigating complex healthcare situations.
  • Personalized Care Innovation: The company's Medicare Advantage and Medicaid plans provide funding for nutritious food, over-the-counter medications, and transportation services, which contribute to improved health outcomes and reflect Elevance's commitment to addressing individual health needs.
  • Community Partnership Expansion: Elevance Health invests in community relationships, leveraging data to understand health determinants, and implements initiatives like on-site food pantries in schools, thereby enhancing overall community health and strengthening local influence.
  • Data-Driven Care Coordination: The Community Pharmacy Total Care program collaborates with independent pharmacies to offer personalized solutions for members with complex health conditions, improving management of diabetes and chronic diseases, which enhances service quality and member satisfaction.
[object Object]
Preview
6.0
01:12 AMNewsfilter
Elevance Health's Subsidiaries Rated A (Excellent) by AM Best
  • Rating Upgrade: AM Best upgraded the financial strength rating of Elevance Health's Blue Cross Blue Shield insurance subsidiaries to A (Excellent), reflecting their strong balance sheet and operational performance, which is expected to enhance investor confidence and market competitiveness.
  • Financial Stability: Anthem Health's financial leverage increased to approximately 42%, but is expected to decline back to the targeted 40% by year-end 2025, indicating the company's ability to maintain financial health while expanding its market presence.
  • Liquidity Assurance: Anthem Health has access to a $5 billion revolving credit facility and a $5 billion commercial paper program, ensuring liquidity over the next few years to support ongoing business expansion and acquisition activities.
  • Market Share Growth: Elevance operates BCBS plans in 14 states and is actively acquiring in various insurance markets, further solidifying its market leadership, which is expected to drive future revenue growth and profitability.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Elevance Health Inc (ELV) stock price today?

The current price of ELV is 359.07 USD — it has decreased -0.32 % in the last trading day.

arrow icon

What is Elevance Health Inc (ELV)'s business?

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

arrow icon

What is the price predicton of ELV Stock?

Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is 392.07 USD with a low forecast of 343.00 USD and a high forecast of 425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Elevance Health Inc (ELV)'s revenue for the last quarter?

Elevance Health Inc revenue for the last quarter amounts to 50.71B USD, increased 12.33 % YoY.

arrow icon

What is Elevance Health Inc (ELV)'s earnings per share (EPS) for the last quarter?

Elevance Health Inc. EPS for the last quarter amounts to 5.32 USD, increased 22.02 % YoY.

arrow icon

What changes have occurred in the market's expectations for Elevance Health Inc (ELV)'s fundamentals?

The market is revising Upward the revenue expectations for Elevance Health, Inc. (ELV) for FY2025, with the revenue forecasts being adjusted by 0.49% over the past three months. During the same period, the stock price has changed by 15.18%.
arrow icon

How many employees does Elevance Health Inc (ELV). have?

Elevance Health Inc (ELV) has 103158 emplpoyees as of December 13 2025.

arrow icon

What is Elevance Health Inc (ELV) market cap?

Today ELV has the market capitalization of 80.07B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free